c-MET 抗体
(Met Proto-Oncogene (MET))
The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].
Recommended next Filters:
您想试用我们的人工智能搜索吗？
249 results :
MET
适用: 人, 小鼠, 大鼠
WB, ELISA, IHC, IF, ICC
宿主: 兔
Polyclonal
unconjugated
MET
适用: 人, 小鼠, 大鼠
WB, ELISA, IF, ICC
宿主: 兔
Polyclonal
unconjugated
MET
适用: 人, 小鼠, 大鼠
WB, ELISA, IHC, IF, ICC
宿主: 兔
Polyclonal
unconjugated
MET
适用: 人, 小鼠, 大鼠
WB, ELISA, IF, ICC
宿主: 兔
Polyclonal
unconjugated
MET
适用: 人, 小鼠
WB, ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro)
宿主: 兔
Polyclonal
unconjugated
MET
适用: 人, 小鼠, 大鼠
WB, ELISA, IF, ICC
宿主: 兔
Polyclonal
unconjugated
MET
适用: 人
WB, ELISA, IHC, IHC (p)
宿主: 兔
Polyclonal
unconjugated
Latest Publications for our c-MET 抗体
: "Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy." in: Nature communications, Vol. 11, Issue 1, pp. 1304, (2020) (PubMed).: "The unfolded protein response modulators GSK2606414 and KIRA6 are potent KIT inhibitors." in: Cell death & disease, Vol. 10, Issue 4, pp. 300, (2020) (PubMed).
: "Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels. ..." in: Nature communications, Vol. 9, Issue 1, pp. 5069, (2019) (PubMed).
: "Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma." in: Molecular cancer research : MCR, Vol. 17, Issue 4, pp. 929-936, (2019) (PubMed).
: "A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma." in: Scientific reports, Vol. 9, Issue 1, pp. 4902, (2019) (PubMed).
: "Broad-spectrum receptor tyrosine kinase inhibitors overcome de novo and acquired modes of resistance to EGFR-targeted therapies in colorectal cancer." in: Oncotarget, Vol. 10, Issue 13, pp. 1320-1333, (2019) (PubMed).
: "Induction of MET Receptor Tyrosine Kinase Down-regulation through Antibody-mediated Receptor Clustering." in: Scientific reports, Vol. 9, Issue 1, pp. 1988, (2019) (PubMed).
: "Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells." in: BMC cancer, Vol. 19, Issue 1, pp. 496, (2019) (PubMed).
: "Hepatocyte growth factor (HGF) optimizes oral traumatic ulcer healing of mice by reducing inflammation." in: Cytokine, Vol. 99, pp. 275-280, (2018) (PubMed).
: "Premyogenic progenitors derived from human pluripotent stem cells expand in floating culture and differentiate into transplantable myogenic progenitors." in: Scientific reports, Vol. 8, Issue 1, pp. 6555, (2018) (PubMed).
Aliases for c-MET 抗体
MET proto-oncogene, receptor tyrosine kinase (MET) 抗体met proto-oncogene (Met) 抗体
MET proto-oncogene, receptor tyrosine kinase (Met) 抗体
MET proto-oncogene, receptor tyrosine kinase L homeolog (met.L) 抗体
AI838057 抗体
AUTS9 抗体
c-Met 抗体
c-met 抗体
C-MET 抗体
HGF 抗体
HGFR 抗体
Hgfr 抗体
MET 抗体
met 抗体
met-A 抗体
Par4 抗体
RCCP2 抗体
您还需要查找其他产品吗？
- C-JUN 抗体
- c-FOS 抗体
- BZW2 抗体
- BZW1 抗体
- Bystin-Like 抗体
- Butyrylcholinesterase 抗体
- BUD31 抗体
- BUB3 抗体
- BUB1B 抗体
- BUB1 抗体
- BTRC 抗体
- BTNL9 抗体
- BTNL3 抗体
- BTNL2 抗体
- BTN3A3 抗体
- BTN3A2 抗体
- BTN3A1 抗体
- BTN2A2 抗体
- BTN2A1 抗体
- BTN1A1 抗体
- C-Peptide 抗体
- C-Raf Proto-Oncogene Serine/Threonine Protein Kinase 抗体
- c-Rel 抗体
- C-Type Lectin Domain Family 1, Member B 抗体
- C-Type Lectin Domain Family 4, Member M 抗体
- C-Type Lectin Domain Family 6, Member A 抗体
- C10orf10 抗体
- C10orf2 抗体
- C10orf27 抗体
- C10ORF90 抗体
- C10ORF96 抗体
- C11orf46 抗体
- C11orf54 抗体
- C11orf68 抗体
- C11orf73 抗体
- C11ORF74 抗体
- C11orf82 抗体
- C12orf11 抗体
- C12orf53 抗体
- C12orf65 抗体
You are here:
